Company Filing History:
Years Active: 1977-1980
Title: Horst Uthemann: Innovator in Pharmacology
Introduction
Horst Uthemann is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmacology, particularly through his innovative patents. With a total of 2 patents, Uthemann's work focuses on compounds that exhibit valuable therapeutic properties.
Latest Patents
Uthemann's latest patents include the development of acyl derivatives of hellebrigenin. These compounds are characterized by a general formula where R represents various chemical groups, including 2,2-dimethylethenyl and isopropyl. The compounds demonstrate cardioactivity, including a bradycardic effect, and possess local anesthetic, spasmolytic, and antiarrhythmic activities. Another significant patent involves derivatives of desglucohellebrin, which exhibit positive inotropic effects, particularly noted in oral or enteral applications. These compounds are distinguished by their favorable pharmacological properties compared to known alternatives.
Career Highlights
Horst Uthemann is associated with Deutsche Gold- und Silber-Scheideanstalt Vormals Roessler, where he has been instrumental in advancing research in pharmacology. His work has contributed to the development of compounds that hold promise for various therapeutic applications.
Collaborations
Uthemann has collaborated with notable colleagues, including Otto Isaac and Klaus Posselt. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmacological compounds.
Conclusion
Horst Uthemann's contributions to pharmacology through his patents highlight his role as an innovator in the field. His work continues to influence the development of therapeutic compounds with significant medical potential.